These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 24106335)

  • 1. Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update.
    Sommer IE; van Westrhenen R; Begemann MJ; de Witte LD; Leucht S; Kahn RS
    Schizophr Bull; 2014 Jan; 40(1):181-91. PubMed ID: 24106335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis.
    Çakici N; van Beveren NJM; Judge-Hundal G; Koola MM; Sommer IEC
    Psychol Med; 2019 Oct; 49(14):2307-2319. PubMed ID: 31439071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis.
    Sommer IE; de Witte L; Begemann M; Kahn RS
    J Clin Psychiatry; 2012 Apr; 73(4):414-9. PubMed ID: 22225599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive use of anti-inflammatory drugs for schizophrenia: A meta-analytic investigation of randomized controlled trials.
    Cho M; Lee TY; Kwak YB; Yoon YB; Kim M; Kwon JS
    Aust N Z J Psychiatry; 2019 Aug; 53(8):742-759. PubMed ID: 30864461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled study of the efficacy of six-month supplementation with concentrated fish oil rich in omega-3 polyunsaturated fatty acids in first episode schizophrenia.
    Pawełczyk T; Grancow-Grabka M; Kotlicka-Antczak M; Trafalska E; Pawełczyk A
    J Psychiatr Res; 2016 Feb; 73():34-44. PubMed ID: 26679763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia.
    Müller N; Riedel M; Scheppach C; Brandstätter B; Sokullu S; Krampe K; Ulmschneider M; Engel RR; Möller HJ; Schwarz MJ
    Am J Psychiatry; 2002 Jun; 159(6):1029-34. PubMed ID: 12042193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial.
    Akhondzadeh S; Tabatabaee M; Amini H; Ahmadi Abhari SA; Abbasi SH; Behnam B
    Schizophr Res; 2007 Feb; 90(1-3):179-85. PubMed ID: 17208413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic-minocycline-acetylcysteine combination for positive, cognitive, and negative symptoms of schizophrenia.
    Koola MM
    Asian J Psychiatr; 2019 Feb; 40():100-102. PubMed ID: 30776665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials.
    Nitta M; Kishimoto T; Müller N; Weiser M; Davidson M; Kane JM; Correll CU
    Schizophr Bull; 2013 Nov; 39(6):1230-41. PubMed ID: 23720576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of anti-inflammatory agents for symptoms of schizophrenia.
    Keller WR; Kum LM; Wehring HJ; Koola MM; Buchanan RW; Kelly DL
    J Psychopharmacol; 2013 Apr; 27(4):337-42. PubMed ID: 23151612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 12-month, double-blind N-acetyl cysteine on symptoms, cognition and brain morphology in early phase schizophrenia spectrum disorders.
    Breier A; Liffick E; Hummer TA; Vohs JL; Yang Z; Mehdiyoun NF; Visco AC; Metzler E; Zhang Y; Francis MM
    Schizophr Res; 2018 Sep; 199():395-402. PubMed ID: 29588126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial.
    Laan W; Grobbee DE; Selten JP; Heijnen CJ; Kahn RS; Burger H
    J Clin Psychiatry; 2010 May; 71(5):520-7. PubMed ID: 20492850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial.
    Husain MI; Chaudhry IB; Khoso AB; Husain MO; Hodsoll J; Ansari MA; Naqvi HA; Minhas FA; Carvalho AF; Meyer JH; Deakin B; Mulsant BH; Husain N; Young AH
    Lancet Psychiatry; 2020 Jun; 7(6):515-527. PubMed ID: 32445690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoregulatory and/or Anti-inflammatory Agents for the Management of Core and Associated Symptoms in Individuals with Autism Spectrum Disorder: A Narrative Review of Randomized, Placebo-Controlled Trials.
    Arteaga-Henríquez G; Gisbert L; Ramos-Quiroga JA
    CNS Drugs; 2023 Mar; 37(3):215-229. PubMed ID: 36913130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of anti-inflammatory agents in treatment of psychotic disorders - A comprehensive systematic review and meta-analysis.
    Jeppesen R; Christensen RHB; Pedersen EMJ; Nordentoft M; Hjorthøj C; Köhler-Forsberg O; Benros ME
    Brain Behav Immun; 2020 Nov; 90():364-380. PubMed ID: 32890697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study.
    Farokhnia M; Azarkolah A; Adinehfar F; Khodaie-Ardakani MR; Hosseini SM; Yekehtaz H; Tabrizi M; Rezaei F; Salehi B; Sadeghi SM; Moghadam M; Gharibi F; Mirshafiee O; Akhondzadeh S
    Clin Neuropharmacol; 2013; 36(6):185-92. PubMed ID: 24201233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Double-Blind, Randomized, Placebo-Controlled Study of Aspirin and N-Acetylcysteine as Adjunctive Treatments for Bipolar Depression.
    Bauer IE; Green C; Colpo GD; Teixeira AL; Selvaraj S; Durkin K; Zunta-Soares GB; Soares JC
    J Clin Psychiatry; 2018 Dec; 80(1):. PubMed ID: 30549489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib augmentation of continuously ill patients with schizophrenia.
    Rapaport MH; Delrahim KK; Bresee CJ; Maddux RE; Ahmadpour O; Dolnak D
    Biol Psychiatry; 2005 Jun; 57(12):1594-6. PubMed ID: 15953498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effect of adjunctive N-acetyl cysteine (NAC) on symptoms of chronic schizophrenia: A double-blind, randomized clinical trial.
    Sepehrmanesh Z; Heidary M; Akasheh N; Akbari H; Heidary M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Mar; 82():289-296. PubMed ID: 29126981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia.
    Levkovitz Y; Mendlovich S; Riwkes S; Braw Y; Levkovitch-Verbin H; Gal G; Fennig S; Treves I; Kron S
    J Clin Psychiatry; 2010 Feb; 71(2):138-49. PubMed ID: 19895780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.